Wolff Wiese Magana’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
WAM
RFM
NHFG
MFS
LRPA
SGH
EWM
Wolff Wiese Magana's XBI Position: Q2 2026 in Review
Wolff Wiese Magana reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.3% in Q2 2026, selling an estimated $3.38K and leaving 1,066 shares worth $169K. The position accounts for 0.08% of the portfolio, ranked #130.
Wolff Wiese Magana first reported a position in XBI in Q4 2020 and has held it in 23 quarters since. The position peaked at $184K in Q4 2020. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Wolff Wiese Magana held 1,066 shares of State Street SPDR S&P Biotech ETF worth $169K as of Q2 2026.
- Wolff Wiese Magana sold 25 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.38K.
- State Street SPDR S&P Biotech ETF made up 0.08% of Wolff Wiese Magana's portfolio in Q2 2026, its #130 holding.
- Wolff Wiese Magana first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 23 quarters since.
- Wolff Wiese Magana's State Street SPDR S&P Biotech ETF position peaked at $184K in Q4 2020.
- 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.